Platelet Rich Plasma Market, By Type (Pure PRP, Leukocyte rich PRP, Pure PRF, and Leukocyte rich PRF), By Origin (Autologous, Allogenic, and Homologues), By Application (Neurosurgery, Cosmetic Surgery, Orthopedic Surgery, General Surgery, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Apr 2024

Code : CMI936

Pages :184

Formats :

Excel and PDF

Industry : Biotechnology

Key Developments

In December 2023, Hairline International Hair and Skin Clinic, the hair clinic, announced the launch of an advanced hair regeneration therapy called Sonicated PRP, based on groundbreaking research utilizing platelet-rich plasma (PRP). The cutting-edge treatment, aims to revolutionize hair follicle activation and regeneration.
In January 2023, RegenOrthoSport, an orthopedic clinic, in Mumbai, Maharashtra, announced that it had received an approval from the National Ethics Committee Registry for Biomedical and Health Research (NECRBHR), under the Ministry of Health and Family Welfare for the use of Autologous Bone Marrow Aspirate Concentrate (BMAC) and Platelet Rich Plasma (PRP) on patients affected with musculoskeletal disorders
In May, 2022, Ester Medical, a pharmaceutical company announced that it had signed an agreement with Aesthetic Management for exclusive long-term marketing and distribution of Eclipse PRP and Tropocells in the U.S. market.
In March 2020, EmCyte Corporation, a manufacturer of medical devices announced the acquisition of all of the assets of Cellmedix Holdings, a biotechnology company, including its Centrepid Platelet Concentrator system. EmCyte’s acquisition of Cellmedix Holdings LLC’s (Cellmedix) assets could expands its intellectual property profile and product development capabilities.